BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 15508107)

  • 1. Iron, hemochromatosis, and hepatocellular carcinoma.
    Kowdley KV
    Gastroenterology; 2004 Nov; 127(5 Suppl 1):S79-86. PubMed ID: 15508107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in the HFE gene and their interaction with exogenous risk factors in hepatocellular carcinoma.
    Fargion S; Stazi MA; Fracanzani AL; Mattioli M; Sampietro M; Tavazzi D; Bertelli C; Patriarca V; Mariani C; Fiorelli G
    Blood Cells Mol Dis; 2001; 27(2):505-11. PubMed ID: 11500061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations of the HFE gene and the risk of hepatocellular carcinoma.
    Racchi O; Mangerini R; Rapezzi D; Gaetani GF; Nobile MT; Picciotto A; Ferraris AM
    Blood Cells Mol Dis; 1999; 25(5-6):350-3. PubMed ID: 10660482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation of hemochromatosis with hepatocellular carcinoma: epidemiology, natural history, pathophysiology, screening, treatment, and prevention.
    Harrison SA; Bacon BR
    Med Clin North Am; 2005 Mar; 89(2):391-409. PubMed ID: 15656932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver iron, HFE gene mutations, and hepatocellular carcinoma occurrence in patients with cirrhosis.
    Nahon P; Sutton A; Rufat P; Ziol M; Thabut G; Schischmanoff PO; Vidaud D; Charnaux N; Couvert P; Ganne-Carrie N; Trinchet JC; Gattegno L; Beaugrand M
    Gastroenterology; 2008 Jan; 134(1):102-10. PubMed ID: 18061182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver transplantation normalizes serum hepcidin level and cures iron metabolism alterations in HFE hemochromatosis.
    Bardou-Jacquet E; Philip J; Lorho R; Ropert M; Latournerie M; Houssel-Debry P; Guyader D; Loréal O; Boudjema K; Brissot P
    Hepatology; 2014 Mar; 59(3):839-47. PubMed ID: 23775519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular carcinoma in a patient with hereditary hemochromatosis and noncirrhotic liver. A case report.
    Köhler HH; Höhler T; Küsel U; Kirkpatrick CJ; Schirmacher P
    Pathol Res Pract; 1999; 195(7):509-13. PubMed ID: 10448668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic iron overload: direct HFE (HLA-H) mutation analysis vs quantitative iron assays for the diagnosis of hereditary hemochromatosis.
    Press RD; Flora K; Gross C; Rabkin JM; Corless CL
    Am J Clin Pathol; 1998 May; 109(5):577-84. PubMed ID: 9576576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of hepatic iron overload and association with hepatocellular cancer in end-stage liver disease: results from the National Hemochromatosis Transplant Registry.
    Ko C; Siddaiah N; Berger J; Gish R; Brandhagen D; Sterling RK; Cotler SJ; Fontana RJ; McCashland TM; Han SH; Gordon FD; Schilsky ML; Kowdley KV
    Liver Int; 2007 Dec; 27(10):1394-401. PubMed ID: 17927713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between heterozygosity for HFE gene mutations and hepatitis viruses in hepatocellular carcinoma.
    Fracanzani AL; Fargion S; Stazi MA; Valenti L; Amoroso P; Cariani E; Sangiovanni A; Tommasini M; Rossini A; Bertelli C; Fatta E; Patriarca V; Brescianini S; Stroffolini T
    Blood Cells Mol Dis; 2005; 35(1):27-32. PubMed ID: 15894495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hereditary hemochromatosis in a Brazilian university hospital in São Paulo State (1990-2000).
    Martinelli AL; Filho R; Cruz S; Franco R; Tavella M; Secaf M; Ramalho L; Zucoloto S; Rodrigues S; Zago M
    Genet Mol Res; 2005 Mar; 4(1):31-8. PubMed ID: 15841433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic iron metabolism gene expression profiles in HFE associated hereditary hemochromatosis.
    Gleeson F; Ryan E; Barrett S; Russell J; Crowe J
    Blood Cells Mol Dis; 2007; 38(1):37-44. PubMed ID: 17098454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hereditary hemochromatosis.
    Fix OK; Kowdley KV
    Minerva Med; 2008 Dec; 99(6):605-17. PubMed ID: 19034258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-factors in liver disease: the role of HFE-related hereditary hemochromatosis and iron.
    Wallace DF; Subramaniam VN
    Biochim Biophys Acta; 2009 Jul; 1790(7):663-70. PubMed ID: 18848602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron in the pathogenesis of hepatocellular carcinoma.
    Fargion S; Piperno A; Fracanzani AL; Cappellini MD; Romano R; Fiorelli G
    Ital J Gastroenterol; 1991 Dec; 23(9):584-8. PubMed ID: 1662094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron, the HFE gene, and hepatitis C.
    Eisenbach C; Gehrke SG; Stremmel W
    Clin Liver Dis; 2004 Nov; 8(4):775-85, vii-viii. PubMed ID: 15464655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Iron overload disease: recent findings].
    Licata A; Brucato V; Di Marco V; Barbaria F; Craxì A
    Ann Ital Med Int; 2004; 19(3):145-54. PubMed ID: 15529941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in HFE causing hemochromatosis are associated with primary hypertriglyceridemia.
    Solanas-Barca M; Mateo-Gallego R; Calmarza P; Jarauta E; Bea AM; Cenarro A; Civeira F
    J Clin Endocrinol Metab; 2009 Nov; 94(11):4391-7. PubMed ID: 19820015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hereditary and acquired iron overload].
    de Korwin JD
    Nephrol Ther; 2006 Nov; 2 Suppl 5():S304-12. PubMed ID: 17373275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between genotype and phenotype in hereditary hemochromatosis: analysis of 61 cases.
    Sham RL; Ou CY; Cappuccio J; Braggins C; Dunnigan K; Phatak PD
    Blood Cells Mol Dis; 1997 Aug; 23(2):314-20. PubMed ID: 9410475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.